The deal has analysts puzzled, as the US maker of Tylenol has seen sales dip after the White House linked it to autism.
Kimberly-Clark to buy Tylenol maker Kenvue for $40bn
Related Posts
‘Melania’: What to know about the US first lady’s new documentary
The film’s high budget has raised questions about efforts by powerful donors to win favour with the White House.
France moves to ban social media for users under 15
France is moving closer to banning social media for users under the age of 15, over growing concerns over mental health.